Mark Alles

Provides pharmaceutical research and biotechnology services

Operates as a trade association which promotes pharmaceutical discovery and development

The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024.

Provides support services to cancer patients

Develops pharmaceutical technology

Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies

Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases

Develops CAR-T therapy platform for cancer therapies

Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies

Develops AI powered protein therapeutics discovery platform

Operates as a clinical-stage biopharmaceutical company that develops antibody-based medicines for cancer patients